Search Results - "Parraga, Ivonne"

Study of the frequency and reasons for discontinuation of different lines of treatment in patients with multiple myeloma by Senín, Alicia, García-Pallarols, Francesc, Ben Azaiz, Randa, Martínez-Serra, Laia, Montesdeoca, Sara, Román, David, Ferraro, Mariana, Párraga, Ivonne, Besses, Carlos, Abella, Eugenia

“…The availability of new agents for the treatment of multiple myeloma has allowed the use of multiple lines of treatment, but a percentage of patients do not…”
Get full text

Generation of a New Prognostic Index for Chronic Myelomonocytic Leukemia (CMML) Based on Peripheral Blood Assessment by Roman, David, Arenillas, Leonor, Parraga, Ivonne, Florensa, Lourdes, Montesdeoca, Sara, Salido, Marta, Anna, Puiggros, Espinet, Blanca, Colomo, Lluís, Andrade, Marcio, Merchan, Brayan, Ferrer, Ana, Calvo, Xavier

“…Introduction The majority of prognostic indexes in CMML include information extracted from bone marrow (BM) evaluation. The blast count in BM in CMML includes…”
Get full text

Diagnostic Utility of Flow Cytometric Immunophenotyping in Chronic Myelomonocytic Leukemia by Arenillas, Leonor, Parraga, Ivonne, Florensa, Lourdes, Montesdeoca Romero, Sara, Puiggros, Anna, Salido, Marta, Espinet, Blanca, Angona, Anna, Ferrer, Ana, Pedro, Carme, Calvo, Xavier

“…INTRODUCTION The diagnosis of chronic myelomonocytic leukemia (CMML) according to WHO 2017 requires the presence of ≥1x109/L and ≥10% of monocytes in…”
Get full text

Immunophenotypic Characteristics of Olygomonocytic Chronic Myelomonocytic Leukemia Support Its Diagnosis As a Distinctive Entity in the Continuum of Chronic Myelomonocytic Leukemia by Calvo, Xavier, Parraga, Ivonne, Florensa, Lourdes, Montesdeoca Romero, Sara, Puiggros, Anna, Salido, Marta, Espinet, Blanca, Angona, Anna, Ferrer, Ana, Pedro, Carme, Arenillas, Leonor

“…INTRODUCTION The diagnosis of chronic myelomonocytic leukemia (CMML) according to WHO 2017 requires the presence of ≥1x109/L and ≥10% of monocytes in…”
Get full text

Oligomonocytic Chronic Myelomonocytic Leukemia (O-CMML) and Chronic Myelomonocytic Leukemia (CMML) Show Similar Clinical, Morphological, Immunophenotypic and Molecular Features by Calvo, Xavier, Garcia-Gisbert, Nieves, Parraga, Ivonne, Florensa, Lourdes, Montesdeoca, Sara, Fernández, Concepción, Salido, Marta, Puiggros, Anna, Espinet, Blanca, Bellosillo, Beatriz, Colomo, Lluís, Roman, David, Andrade, Marcio, Merchan, Brayan, Ferrer, Ana, Arenillas, Leonor

“…INTRODUCTION The 2017 WHO classification requires the presence of ≥1x109/L and ≥10% of monocytes in peripheral blood (PB) for the diagnosis of CMML. Recently,…”
Get full text

High Diagnostic Utility of Flow Cytometry Based Peripheral Blood Monocyte Subset Analysis, CD56 and CD2 Expression in Chronic Myelomonocytic Leukemia (CMML) by Calvo, Xavier, Parraga, Ivonne, Garcia-Gisbert, Nieves, Florensa, Lourdes, Montesdeoca, Sara, Fernández, Concepción, Salido, Marta, Puiggros, Anna, Espinet, Blanca, Bellosillo, Beatriz, Colomo, Lluís, Roman, David, Andrade Campos, Marcio, Merchan, Brayan, Ferrer, Ana, Arenillas, Leonor

“…INTRODUCTION The diagnosis of CMML according to WHO 2017 requires the presence of ≥1x109/L and ≥10% of monocytes in peripheral blood (PB). Establishing an…”
Get full text

Oligomonocytic and overt chronic myelomonocytic leukemia show similar clinical, genomic, and immunophenotypic features by Calvo, Xavier, Garcia-Gisbert, Nieves, Parraga, Ivonne, Gibert, Joan, Florensa, Lourdes, Andrade-Campos, Marcio, Merchan, Brayan, Garcia-Avila, Sara, Montesdeoca, Sara, Fernández-Rodríguez, Concepción, Salido, Marta, Puiggros, Anna, Espinet, Blanca, Colomo, Luís, Roman-Bravo, David, Bellosillo, Beatriz, Ferrer, Ana, Arenillas, Leonor

“…Oligomonocytic chronic myelomonocytic leukemia (OM-CMML) is defined as those myelodysplastic syndromes (MDSs) or myelodysplastic/myeloproliferative neoplasms,…”
Get full text